๐ We are proud to announce Dr. Xin Zhou, Ph.D., as the recipient of theย ๐ฎ๐ฌ๐ฎ๐ฑ ๐๐ฎ๐บ๐ฒ๐ ๐ฆ.ย ๐๐๐๐๐ผ๐ป ๐๐ป๐๐ถ๐ฏ๐ผ๐ฑ๐ ๐ฆ๐ฐ๐ถ๐ฒ๐ป๐ฐ๐ฒ ๐ง๐ฎ๐น๐ฒ๐ป๐ ๐๐๐ฎ๐ฟ๐ฑ!
Dr. Zhou was selected for her pioneering work in protein engineering and chemical biology, advancing understanding of immune signaling, cancer drug resistance, and therapeutic reprogramming.
She will present her research at the upcomingย ๐๐ป๐๐ถ๐ฏ๐ผ๐ฑ๐ย ๐๐ป๐ด๐ถ๐ป๐ฒ๐ฒ๐ฟ๐ถ๐ป๐ดย &ย ๐ง๐ต๐ฒ๐ฟ๐ฎ๐ฝ๐ฒ๐๐๐ถ๐ฐ๐ย ๐ฐ๐ผ๐ป๐ณ๐ฒ๐ฟ๐ฒ๐ป๐ฐ๐ฒย in San Diego this December, and we look forward to her talk.
Dr. Zhou is an Assistant Professor of Biological Chemistry and Molecular Pharmacology atย Harvard Medical Schoolย and of Cancer Biology atย Dana-Farber Cancer Institute.
๐๐ฏ๐ผ๐๐ ๐๐ฟ.ย ๐ญ๐ต๐ผ๐ ๐ฎ๐ป๐ฑ ๐ต๐ฒ๐ฟ ๐น๐ฎ๐ฏ:
She holds a Ph.D. in Bioengineering fromย Stanford University School of Medicineย and completed postdoctoral research atย University of California, San Franciscoย as a Merck โย Damon Runyon Cancer Research Foundationย Fellow.
Since joining Dana-Farber and Harvard in 2022, her lab has developed technologies in protein engineering and chemical biology to study cancer and immune signaling, drug resistance, and metastasis, and to engineer self-regulated antibodies, enzymes, and cells for therapeutic reprogramming.
๐๐ฒ๐ฟ ๐บ๐ฎ๐ป๐ ๐ต๐ผ๐ป๐ผ๐ฟ๐ ๐ถ๐ป๐ฐ๐น๐๐ฑ๐ฒ:
V Foundation Women Scientists Innovation Award for Cancer Research, NIH Directorโs New Innovator Award (DP2), Damon Runyon Dale F. Frey Award for Breakthrough Scientists, Helen Gurley Brown Foundation Trailblazer Award, Dana-Farber Innovations Therapeutic Accelerator LEAP Award, MIT Technology Review Innovators Under 35 (China region), PEGS Protein & Antibody Engineering Summit Young Scientist Keynote Award, and the NIH K99/R00 Pathway to Independence Award.
๐ ๐ฎ๐ป๐ ๐ฐ๐ผ๐ป๐ด๐ฟ๐ฎ๐๐๐น๐ฎ๐๐ถ๐ผ๐ป๐ ๐๐ผ ๐๐ฟ.ย ๐ญ๐ต๐ผ๐ ๐ผ๐ป ๐๐ต๐ถ๐ ๐๐ฒ๐น๐น ๐ฑ๐ฒ๐๐ฒ๐ฟ๐๐ฒ๐ฑ ๐ฟ๐ฒ๐ฐ๐ผ๐ด๐ป๐ถ๐๐ถ๐ผ๐ป! ๐
If you are an early-career scientist interested in participating in next yearโs award, you can learn more about the submission guidelines here:
